Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview with Fernando Lehner, CEO of BVZ Group, on the Business | Fernando Lehner - CEO of bvz holding ag
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Fernando Lehner is the CEO of bvz holding ag
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Exploring the Volatility and Potential of the Vanadium Market with Christopher Recklesson
00:10:00
Sam Garrett Shares Promising Copper-Gold Findings from Especularita’s Victoria Prospect | Sam Garrett, CEO, Great Southern Copper PLC.
00:10:00
Robert F. Smith on the Evolution of Vista Equity Partners and the Future of Software | Robert F. Smith, CEO, Vista Equity Partner.
00:10:00
Alpha Financial Markets Consulting PLC's outgoing CEO Euan Fraser and incoming CEO Luc Baqué discuss the leadership transition with Proactive's Thomas Warner.|Luc is Chief Executive Officer of Alpha
00:00:00
ReNeuron / Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
Email is pivotal in this context|Shawn Carolan,Partner, Menlo Ventures
00:10:00
Navigating Retirement with Confidence: Mortgage Strategies from Carl Gill of Asset Preservation Capital | Carl Gill - Financial Advisor, Asset Preservation Capital
00:10:00
New Pacific Metals Advances with Silver Sand, Karangus, and Silver Strike Projects in Bolivia
00:10:00
Should You Shift to a More Conservative Portfolio as You Near Retirement? | Dana Anspach, CEO , Sensible Money, LLC.
00:00:00
Developing transformative cell and exosome-based therapeutics to treat muscular diseases - Linda Marbán, Ph.D. Chief Executive Officer and Director, Capricor Therapeutics Inc
00:10:00
CEO Thomas Olin on Innovation and Biopharma Advances | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Unlocking the Power of ESG and SRI: Ethical Investing with AIO Financial | Bill Holliday - Certified Financial Planner (CFP) of AIO Financial, LLC